Memory Pharmaceuticals is focused on developing drug candidates for the treatment of central nervous system conditions.
Business Model:
Revenue: $0
Employees: 51-500
Memory Pharmaceuticals was acquired by
Roche.
The acquisition happend on 2008-11-25.
Details of the transaction were not public
Address:
City: Montvale
State: New Jersey
Zip:
Country: United States
Memory Pharmaceuticals Corp., a biopharmaceutical company, focuses on the discovery and development of drug candidates for the treatment of central nervous system conditions. It offers drugs for neurological diseases associated with aging, such as Alzheimer&s;s disease, as well as psychiatric disorders, such as schizophrenia, cognitive impairment associated with schizophrenia (CIAS), and depression. The company was incorporated in 1997 and is based in Montvale, New Jersey. As of December 31, 2008, Memory Pharmaceuticals Corp. operates as a subsidiary of Hoffmann-La Roche Inc.
Contact Phone:
Contact Email:
Listed Exchange:
NASDAQ
IPO Date:
4/5/2004
Ticker Symbol:
MEMY
IPO Price:
$7/share
Amount Raised:
$35M
Opened: -/share
EBITDA | - |
Total Cash | - |
Total Debt | - |
Total Revenue | - |
Total Profit (Gross) | - |
PE Ratio | - |
Announced Date | Company | Transaction | Money Raised |
---|
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 1/1998 | Seed Round | 1 | - |
Venrock Venrock |
9/2005 | Post-IPO Equity | $31M | 3/2007 | Post-IPO Debt | 1 | $10M |
Hercules Capital Hercules Capital |
1/1998 | Seed Round | 1 | - |
Venrock Venrock |
---|
Announced Date | Name | Price |
---|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|